Moreover, the failure of broad-spectrum MMP inhibitors in clinical trials of cancer treatment has led to the development of selective MMP inhibitors [46], and inhibitors that target MMP-9 have been indicated as potential treatments for cancer [47]. This evidence concerns the gene MMP9 and cancer.